GlaxoSmithKline changes its sales and marketing practices to put more focus on patients, CEO says.
Changing Medicare's policy to permit patients to self-administer injectable drugs in their homes could create "substantial savings" without inhibiting patient safety or treatment effectiveness, according to a recent NEJM editorial.
Canaglifozin (Invokana, Janssen Pharmaceuticals) tablets, recently approved by the U.S. Food and Drug Administration for the improvement of glycemic control in adults with type 2 diabetes, is the first diabetes treatment approved in a new class of drugs known as sodium-glucose co-transporter 2 inhibitors.
Walgreens is ready to take retail clinics a step further, with an announcement yesterday that the pharmacy chain will begin offering chronic care in addition to immunizations and acute care.
Giving in to patient demands for brand-name drugs could be adding unnecessary costs to healthcare system
Years in practice, specialty, and practice size were factors when researchers examined the likelihood that a physician would honor a patient's request for a brand-name drug rather than a generic. The investigators suggest two solutions to reduce the practice, which if followed could save costs in the healthcare system.
Many Americans lost their jobs--and their health insurance--during the past few years of recession, but a new study shows that minorities may have been hit the hardest.
Decertification of those with loan debt, workplace violence, "pay for delay" among issues AMA takes up
The AMA has adopted a slew of new advocacy issues, including finding an end to pay for delay, addressing violence against physicians in the workplace, and decertification of physicians with outstanding load debt.